Actively Recruiting
Comparing Mineral Trioxide Aggregate MTA and Biodentine for Pulpotomy and Indirect Pulp Cap in Primary Molars of Children Ages 2 to 12
Led by Geisinger Clinic · Updated on 2025-12-23
646
Participants Needed
1
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are comparing the clinical and radiographic success of two dental medicaments, mineral trioxide aggregate MTA and Biodentine, used in vital pulp therapy for primary molars in children aged 2 to 12 years. The study focuses on treatments called pulpotomy and indirect pulp cap IPC in primary first and second molars of both the upper and lower jaws. Biodentine is a newer product that is less expensive and does not cause tooth discoloration like MTA, making it a potential alternative for pulp therapy in primary teeth. This randomized, interventional study uses a split-mouth design where each participant receives both treatments one side of the mouth will be treated with MTA and the corresponding side with Biodentine. The procedures follow standards from the American Academy of Pediatric Dentistry and are performed in operating rooms at Geisinger Medical Center and Geisinger Bloomsburg Hospital. Treatment involves full mouth rehabilitation with at least two matched bilateral carious primary molars requiring pulpotomy or IPC. Participants will have clinical and radiographic follow-up visits every six months for three years after treatment, conducted at Geisingers Pediatric Dental Clinics. Data from electronic health records and dental radiographs are collected and recorded for analysis. The primary outcomes measured are the rates of clinical and radiographic success of pulpotomies and IPC procedures over a four-year period, with researchers monitoring the health and response of treated teeth throughout the study.
CONDITIONS
Brief Title
Clinical and Radiographic Success of MTA vs Biodentine
Research Team
G
Gayatri Malik, DMD
S
Samantha R Crissinger
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here